← Back to directory

Marc Peeters

Researcher Next ID · RN-007689

Researcher · Medicine

University of Antwerp

Antwerp, Belgium

Not currently recruitingFunding unknown
Works count
1,371
Citation count
46,355
H-index
99
i10-index
504

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Colorectal Cancer Treatments and Studies
Cancer Genomics and Diagnostics
Lung Cancer Treatments and Mutations
Genetic factors in colorectal cancer
Gastric Cancer Management and Outcomes

Publications

  • Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

    New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1414325

  • Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

    The Lancet · 2011 · https://doi.org/10.1016/s0140-6736(11)61742-x

  • Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

    Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2009.27.6055

  • Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

    Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.14.7116

  • Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer

    Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2006.08.1620

Current projects

    No projects listed.